Immutep Limited
IMMPNASDAQHealthcare● Active
$0.37
$-0.01(-2.04%)
Market Cap$54365531
P/E Ratio—
52W High$3.53
52W Low$0.29
Immutep Limited (IMMP) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IMMP · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 24, 2026EPS Actual
-$0.22
Est. -$0.20 · -9.9%
Revenue
$0.01B
Est. $0.01B · -41.5%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 24, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
IMMP reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.03 | — | — | — | $0.01B | — |
| ▼ Q1 FY2026 | Feb 24, 2026 | -$0.20 | -$0.22 | -9.9% | $0.01B | $0.01B | -41.5% |
| ▼ Q3 FY2025 | Aug 28, 2025 | -$0.12 | -$0.18 | -44.0% | $0.00B | — | — |
| ▲ Q1 FY2025 | Feb 26, 2025 | -$0.08 | -$0.01 | +88.7% | $0.00B | $0.00B | +349.7% |
| ▲ Q3 FY2024 | Aug 30, 2024 | -$0.08 | -$0.01 | +86.1% | $0.00B | $0.00B | -6.6% |
| ▲ Q2 FY2024 | Apr 29, 2024 | -$0.09 | -$0.01 | +86.1% | $0.00B | $0.00B | +19.6% |
| ▲ Q3 FY2023 | Sep 28, 2023 | -$0.09 | -$0.01 | +84.8% | $0.00B | $0.00B | -14.4% |
| ▲ Q1 FY2023 | Feb 24, 2023 | -$0.08 | -$0.02 | +80.8% | $0.00B | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 24, 2026Miss
EPS Actual
-$0.22
EPS Est.
-$0.20
EPS Surpr.
-9.9%
Revenue
$0.01B
Q3 FY2025
Aug 28, 2025Miss
EPS Actual
-$0.18
EPS Est.
-$0.12
EPS Surpr.
-44.0%
Revenue
$0.00B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.08
EPS Surpr.
+88.7%
Revenue
$0.00B
Q3 FY2024
Aug 30, 2024Beat
EPS Actual
-$0.01
EPS Est.
-$0.08
EPS Surpr.
+86.1%
Revenue
$0.00B
Q2 FY2024
Apr 29, 2024Beat
EPS Actual
-$0.01
EPS Est.
-$0.09
EPS Surpr.
+86.1%
Revenue
$0.00B
Q3 FY2023
Sep 28, 2023Beat
EPS Actual
-$0.01
EPS Est.
-$0.09
EPS Surpr.
+84.8%
Revenue
$0.00B
Q1 FY2023
Feb 24, 2023Beat
EPS Actual
-$0.02
EPS Est.
-$0.08
EPS Surpr.
+80.8%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $-0.29 | $-0.29 | $-0.29 | 1 |
| Q2 FY2024 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q4 FY2023 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q1 FY2016 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2016 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 24, 2026 | -9.9% | $2.88 | $2.80 | -2.78% |
| ▼ Q3 FY2025 | Aug 28, 2025 | -44.0% | $1.66 | $1.66 | +0.00% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +88.7% | $1.88 | $1.90 | +1.06% |
| ▲ Q3 FY2024 | Aug 30, 2024 | +86.1% | $2.48 | $2.63 | +6.05% |
| ▲ Q2 FY2024 | Apr 29, 2024 | +86.1% | $2.65 | $2.67 | +0.75% |
| ▲ Q3 FY2023 | Sep 28, 2023 | +84.8% | $1.92 | $1.86 | -3.12% |
| ▲ Q1 FY2023 | Feb 24, 2023 | +80.8% | $1.75 | $1.73 | -1.14% |
| — Q3 FY2022 | Jul 28, 2022 | — | $2.23 | $2.21 | -0.90% |
Q1 FY2026-2.78%
Report Date
Feb 24, 2026
EPS Beat/Miss
-9.9%
Price Before
$2.88
Price After
$2.80
Q3 FY2025+0.00%
Report Date
Aug 28, 2025
EPS Beat/Miss
-44.0%
Price Before
$1.66
Price After
$1.66
Q1 FY2025+1.06%
Report Date
Feb 26, 2025
EPS Beat/Miss
+88.7%
Price Before
$1.88
Price After
$1.90
Q3 FY2024+6.05%
Report Date
Aug 30, 2024
EPS Beat/Miss
+86.1%
Price Before
$2.48
Price After
$2.63
Q2 FY2024+0.75%
Report Date
Apr 29, 2024
EPS Beat/Miss
+86.1%
Price Before
$2.65
Price After
$2.67
Q3 FY2023-3.12%
Report Date
Sep 28, 2023
EPS Beat/Miss
+84.8%
Price Before
$1.92
Price After
$1.86
Q1 FY2023-1.14%
Report Date
Feb 24, 2023
EPS Beat/Miss
+80.8%
Price Before
$1.75
Price After
$1.73
Q3 FY2022-0.90%
Report Date
Jul 28, 2022
EPS Beat/Miss
—
Price Before
$2.23
Price After
$2.21
Avg Beat Reaction+0.72%
Avg Miss Reaction-1.39%
Beat Rate5 / 8 quarters
Largest Move+6.05% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IMMP ends December
Immutep Limited (IMMP) most recently reported earnings on February 24, 2026 for Q1 FY2026, posting EPS of $-0.22 — missing the analyst consensus of $-0.20 by -9.9%. The next IMMP earnings date is expected around September 1, 2026.
Each quarter, investors track IMMP earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IMMP revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IMMP's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IMMP earnings · 5 questionsImmutep Limited's next earnings report is expected around September 1, 2026. IMMP typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IMMP historically reports after market close (AMC).
IMMP earnings datewhen is IMMP earningsIMMP next earnings datewhen does IMMP report earningsIMMP earnings calendar
▸ Source: FMP · Immutep Limited SEC filings · US GAAP · Immutep Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026